Home > Drug Search >
  • Status: IND Filing
  •   > 
Drug Filter
Category:
chemistry (78) biology (6)
Clinical Stage:
Pending (3) Active (55) Discontinued (1)
Bio-Type:
CAR T cell therapy (1) Whole antibody (3)
Company:
Hansoh Pharma (1) Jiangsu Hengrui Medicine (5) Merck Serono (1) National Cancer Institute (1) Roche (2) Sanhome Pharmaceutical (1) Sanofi (2) Simcere (1) Sinopharm A-THINK Pharmaceutical (1) WuXi AppTec (1) Kite Pharma (1) Zhongsheng Pharmacy (2) Innovent Biologics (2) Livzon Group (1) Liaoning Haisike pharmaceutical (1) Livzon Group Livzon Pharmaceutical Factory (1) Hangzhou Zhongmei Huadong Pharmaceutical (1) Kelun Pharmaceutical (1) Sichuan Haisco Pharmaceutical (1) Penglai Nuokang Pharmaceutical (1) Zhaoke Pharmaceutical (1) XuanZhu Pharma (1) Fochon Pharmaceuticals (1) Suzhou Sirnaomics Biopharmaceuticals (1) Institute of Pharmacology & Radiation of AMMS (1) Beijing Fengshuo Weikang (1) Baiyunshan Pharmaceutical (1) Shijiazhuang Zhongqi Pharmaceutical (1) Zhejiang Yongning Pharmaceutical (2) Ningbo Ziyuan Pharmaceutical (1) Bossan (1) Chongqing University of Arts and Sciences (1) Luye Pharma (1) Cisen Pharmaceutical (2) Tianjin Institute of Pharmaceutical Research (1) Jianfeng Pharmaceutical (1) Kanion Pharmaceutical (3) Nanjing Advenchen Laboratories (1) Zai Lab (1) China State Institute of Pharmaceutical Industry (CSIPI) (1) Shanghai Genomics (1) Institute of Materia Medica Chinese Academy of Medical Sciences (1) Eleven (1) Institute of Pharmacology & Toxicology of AMMS (1) Shanghai Institute of Materia Medica, Chinese Academy of Sciences (4) HEC Pharm (2) Huadong Medicine (1) Shanghai Haihe Pharmaceutical (1) Fosun Pharma (1) ImQuest BioSciences (1) Shenyang Pharmaceutical University (1) 302 Military Hospital of China (1) Third Military Medical University (1) Tasly Pharm (1) Immune Pharmaceuticals (1) Shanghai Pharma (1) Chinese PLA General Hospital/Medical School of Chinese PLA (1) Sirnaomics (1) Guangzhou Xiangxue Pharmaceuticals (1) Shandong Provincial Institute of Dermatology and Venereology (1) Hangzhou Pharmavaxin (1) Guangzhou Yinnuo Pharmaceutical (1) Fujian Jinshon Biologicalpharmaceutical (1) Hangzhou Adamerck Pharmlabs (2) Shanghai Newsummit Biopharma (2) Shanghai Xianfu Chemical Technology (1) Ocean University of China (1) Nanjing Tech University (1) 浙江浙北药业 (1) Innocare (1) Zhejiang Forever Medicine (1) Foreland Pharma (1) Jingfeng Pharma (1) Hangzhou Advenchen Laboratories (1) Ningbo Shengjian (1) Shanghai Hengrui (4) Hangzhou Tianlong Pharmaceuticals (1) Dongguan Anhao (1) Dongguan Daxin (1) Hangzhou Ruomaixing (1) Jiangsu Shengdi (2) Southeast Pharmaceuticals (1) GNI Group (1) 吉林英联尚德科技开发 (1) Chengdu Shengdi (2) Taizhou QR Pharmaceuticals (1) Jiangsu Shimeikang (1) Chinese Peptide Company (1) Chongqing Fujin Biomedical (1) Dalian Dien Biological Engineering (1) Anke Biotechnology (1) NuoKang Biopharma (1) Beijing Ruiyunhai Biotechnology (1) Jiangsu Medolution (1) Zhejiang University (1) BCN Peptides (1) DiverDrugs (1) Puyi chemical/Gyrochem (1) Signum Dermalogix (1) Dermata (1) Beijing Molike Technology (1) Chengdu Yiping Pharmaceutical Technology (1) Sichuan Yibin Wuliangye Yibin Pharmaceutical (1) Qingdao University (1) Wuhan Kangliyuan (1) Techfields Pharma (1) Yene Pharma (1) Beijing Collab Pharma (1) Samjin (1) Shanghai Allist Pharmaceuticals (1) Chiatai Tianqing (CTTQ) (2)
Indication:
Acne (2) Alzheimer's disease (AD) (3) Arrhythmia (1) Brain ischemia (1) Breast cancer (4) Chronic pain (1) Anaplastic lymphoma kinase (ALK)-positive NSCLC (1) Diabetic macular edema (1) Endometrial cancer (1) Endometriosis (1) Epilepsy/Seizures (1) Erectile dysfunction (ED) (1) Gastric cancer (2) Generalized tonic-clonic status epilepticus (GTCSE) (1) Glioblastoma multiforme (1) Gram-positive and Gram-negative bacterial infections (1) HBV infection (1) HCV infection (4) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Hyperlipidemia (1) Hypertension (1) Leukemia (1) Lung cancer (3) Malignancies (1) Medullary thyroid cancer (MTC) (1) Melanoma (1) Multiple myeloma (MM) (2) Myocardial infarction (MI) (2) Non small cell lung cancer (NSCLC) (5) Non-alcoholic fatty liver disease (NAFLD) (1) Obesity (2) Osteoarthritis (OA) (3) Ovarian cancer (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Psoriasis (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (4) Solid tumours (7) Stable plaque psoriasis (1) Systemic lupus erythematosus (2) Tuberculosis (1) Type 2 diabetes (7) Uveitis (1) Venous thromboembolism (VTE) (1) Cardiac ischemic complications (1) Systemic bacterial infections (3) Colon cancer (1) Chronic heart failure (2) Pain (2) Anesthesia (1) HER2-positive metastatic breast cancer (1) Renal carcinoma (1) Hyperphosphatemia (1) Gastrointestinal motility disorders (1) Ischemic stroke (1) Esophagus cancer (1) Gout (1) Thrombosis (2) Alopecia (1) Diffuse large B cell lymphoma (1) Skin hypertrophic scars (1) Urinary tract stones (1) Liver cancer (1) Liver failure (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top